Semaglutide 10mg
This GLP-1 receptor agonist has demonstrated outstanding results in diabetes and obesity treatment, with studies showing average weight loss of 15-17% in non-diabetic individuals. Research has shown significant improvements in cardiovascular outcomes, reducing major adverse cardiac events by 20% in high-risk patients. Studies have documented its ability to improve glycemic control, reduce appetite, and potentially protect against neurodegenerative diseases. The peptide has gained FDA approval for both diabetes and weight management, becoming one of the most prescribed and studied medications in metabolic medicine.
This GLP-1 receptor agonist has demonstrated outstanding results in diabetes and obesity treatment, with studies showing average weight loss of 15-17% in non-diabetic individuals. Research has shown significant improvements in cardiovascular outcomes, reducing major adverse cardiac events by 20% in high-risk patients. Studies have documented its ability to improve glycemic control, reduce appetite, and potentially protect against neurodegenerative diseases. The peptide has gained FDA approval for both diabetes and weight management, becoming one of the most prescribed and studied medications in metabolic medicine.
Purity: ≥99% Purity · Formula: C187H291N45O59 · CAS: 910463-68-2
Fulfilled and shipped direct by MedFit. Orders are confirmed by email, and we follow up on protocol questions ourselves — call the studio any time.